-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

703. Cellular Immunotherapies: Basic and Translational: Poster III

Symposia: Cellular Immunotherapies: Basic and Translational Program: Oral and Poster Abstracts
Type: Poster
Monday, December 12, 2022: 6:00 PM-8:00 PM
Hall D (Ernest N. Morial Convention Center)

Lisa Rohrbacher1,2*, Daniel Nixdorf1,2*, Helena Stadler1,2*, Bettina Brauchle1,2*, Florian Märkl3*, Nora Phillip1,2*, Gerulf Hänel1,2*, Anetta Marcinek1,2*, Maryam Kazerani, PhD1,2*, Rebecca Goldstein4*, Michael von Bergwelt, Prof. Dr.2*, Sebastian Kobold, Prof. Dr.3,5,6*, Veit L Buecklein1,2*, Tara Chapman-Arvedson4 and Marion Subklewe, MD1,5,7

1Laboratory for Translational Cancer Immunology, Gene Center, LMU, Munich, Germany
2Department of Medicine III, University Hospital, LMU Munich, Munich, Germany
3Center of Integrated Protein Science Munich (CIPS-M) and Division of Clinical Pharmacology, University Hospital, LMU Munich, Munich, Germany
4AMGEN Research, AMGEN Inc., South San Francisco, CA
5German Cancer Consortium (DKTK) and German Cancer Research Center (DKFZ), Heidelberg, Germany
6Einheit für Klinische Pharmakologie (EKLiP), Helmholtz Munich, Research Center for Environmental Health (HMGU), Neuherberg, Germany
7Department of Medicine III (Hematology/Oncology), LMU University Hospital Munich, Muenchen, Germany

Mateusz Legut, PhD1*, Maria Guarino2*, Xinhe Xue2*, Congyi Lu2*, Radha Vyas2*, Catherine S. Diefenbach, MD3 and Neville Sanjana, PhD4*

1NY Genome Center, NYC, NY
2New York Genome Center, New York, NY
3Perlmutter Cancer Center at NYU Langone Health, New York, NY
4Perlmutter Cancer Center, New York Genome Center; New York University School of Medicine, New York, NY

Vincenzo Maria Perriello, MD, PhD1*, Maria Caterina Rotiroti, PhD2*, Ilaria Pisani3*, Stefania Galimberti, PhD4*, Gaia Alberti, PhD3*, Giulia Pianigiani, PhD1*, Valerio Ciaurro1*, Andrea Marra, MD1*, Marcella Sabino, PhD1*, Valentina Tini1*, Federica Mezzasoma, PhD1*, Francesco Morena, PhD5*, Sabata Martino, PhD5*, Domenico Salerno, PhD6*, Julian François Ashby7*, Brittany Wingham7*, Marta Serafini, PhD3*, Maria Paola Martelli, MD, PhD1, Brunangelo Falini, MD1, Andrea Biondi, MD, PhD3 and Sarah Tettamanti, PhD3*

1Institute of Hematology, University and Hospital of Perugia, Perugia, Italy
2Department of Pediatrics, Stanford University School of Medicine, Stanford, CA
3Tettamanti Research Center, Department of Pediatrics, University of Milano - Bicocca/Fondazione MBBM, Monza, Italy
4Center of Biostatistics for Clinical Epidemiology, University of Milano-Bicocca, Monza, Italy
5Department of Chemistry, Biology and Biotechnology, University of Perugia, Perugia, Italy
6Department of Medicine and Surgery, University of Milano - Bicocca, Monza, Italy
7LUMICKS, Amsterdam, Netherlands

Shweta Bansil, MD1*, Cecilia Motta, PhD1*, Rachel Dicioccio1*, Samuel O'Brien1*, Haili Lang, MD1*, Michael Keller, MD1*, Allistair Abraham, MD1*, David Jacobsohn, MD1, Blachy J Davila Saldana, MD1, Amanda L. Olson, MD2, Elizabeth J Shpall, MD2, Indreshpal Kaur, PhD2*, Patrick J Hanley, PhD1* and Catherine M Bollard, MD1

1Children's National Medical Center, Washington, DC
2Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX

Alexander W. Rankin, MD and Mark Eric Kohler, MD, PhD

Children's Hospital Colorado, University of Colorado School of Medicine, Aurora, CO

Georgia Koutsoumpli, MSc1*, Dyantha I. van der Lee, BSc1*, Nina C. Groenland, BSc1*, M. Willy Honders, ing.1*, Rob C.M. de Jong, PhD1*, Renate S. Hagedoorn, ing.1*, Hendrik Veelken, MD, PhD2, Peter A. van Veelen3*, Dominik Lock, PhD4*, Mirjam H.M. Heemskerk2, J.H.Frederik Falkenburg, MD, PhD2, Ian Johnston, PhD4* and Marieke Griffioen2*

1Department of Hematology, Leiden University Medical Center (LUMC), Leiden, Netherlands
2Department of Hematology, Leiden University Medical Center, Leiden, Netherlands
3Center for Proteomics and Metabolomics, Leiden University Medical Center, Leiden, Netherlands
4Miltenyi Biotec B.V. & Co. KG, Bergisch Gladbach, Germany

Heather Lin, BS1*, A K M Nawshad Hossian, PhD2*, Biaggio Uricoli, BS3*, Ruby Mei Freeman, BS4*, Dejah A Blake, BS, MS5*, Jonathan Legier, BS2*, Remya Nair, PhD4*, Jean L. Koff, MD, MSc6, Mala Shanmugam, PhD7, Erik Dreaden, PhD3* and Sarwish Rafiq, PhD4

1Department of Cancer Biology, Emory University School of Medicine, Atlanta, GA
2Emory University, Atlanta, GA
3Wallace H. Coulter Department of Biomedical Engineering at Georgia Tech and Emory University, Atlanta, GA
4Department of Hematology and Medical Oncology, Winship Cancer Institute, Emory University School of Medicine, Atlanta, GA
5Laney Graduate School, Department of Cancer Biology, Emory University, Atlanta, GA
6Winship Cancer Institute, Emory University School of Medicine, Atlanta, GA
7Department of Hematology and Medical Oncology, Winship Cancer Institute, Emory University School of Medicine, Winship Cancer Institute, Atlanta, GA

Martina Pigazzi, MMSc, PhD1*, Olivia Marini, PhD1*, Elena Porcù1*, Giovanni Faggin1*, Elena Varotto, MD, PhD1*, Paolo Rizzardi2*, Barbara Buldini1*, Franco Locatelli, Prof., MD, PhD3 and Alessandra Biffi1*

1Women's and children's health department, onco-hematology lab and clinic, University-Hospital of Padova, Padova, Italy
2Altheia science, Milan, Italy
3Department of Pediatric Hematology/Oncology, Cell and Gene Therapy, IRCCS Bambino Gesù Children's Hospital, Rome, Italy

Mark Gurney, MB BCh BAO1*, Margaret Twohig, MSc1*, Derya Goksu Helvaci1*, Eimear O'Reilly, PhD2*, Sarah Brophy, PhD2*, Janusz Krawczyk, MD1, David L. Hermanson, PhD3*, Eva Szegezdi, PhD1* and Michael E. O'Dwyer, MD1,2

1National University of Ireland Galway, Galway, Ireland
2ONK Therapeutics, Galway, Ireland
3Bio-Techne, Minneapolis

Eider Moreno, MD1*, Pedro Franco-Fuquen, MD1*, Jose V. Forero, MD2, Juan Esteban Garcia Robledo, MD1*, Natalie Booth, DO1,3* and Januario E. Castro, MD1

1Division of Hematology and Medical Oncology, Mayo Clinic, Phoenix, AZ
2Division of Internal Medicine, The Ohio State University Wexner Medical Center, Columbus, OH
3Center for Cancer and Blood Disorders, Phoenix Children’s Hospital, Phoenix, AZ

Soheila Shirinbak1*, Joy Grant1*, Wen-I Yeh, PhD2*, Angela Gentile3*, Bishwas Shrestha, PhD1, Bi-Huei Yang, PhD1*, Mochtar Pribadi, PhD1*, Shohreh Sikaroodi, PhD4*, Amit Mehta, PhD3*, Amanda D Yzaguirre, PhD4*, Yijia Pan, PhD4*, Chia-Wei Chang, PhD3*, Tom Lee, PhD4*, Layton Smith1*, Jianming Wu, PhD5*, Bruce Walcheck, PhD6*, Martin Hosking, PhD3* and Bahram Valamehr3

1Fate Therapeutics Inc. (FHQ1), San Diego, CA
2FateTherapeutics, Inc., San Diego, CA
3Fate Therapeutics, Inc., San Diego, CA
4Fate Therapeutics Inc., San Diego, CA
5University of Minnesota, Veterinary and Biomedical Sciences, Saint Paul, MN
6Veterinary and Biomedical Sciences, University of Minnesota, Saint Paul, MN

Ziran Zhao, PhD1,2,3,4, McKensie Collins, PhD2,3,4, Clare Sun, MD5, Adrian Wiestner, MD, PhD5 and J. Joseph Melenhorst, PhD1,3,6,7,8

1Lerner Research Institute, Center for ImmunoTherapy & Precision Immuno-Oncology, Cleveland Clinic, Cleveland, OH
2Department of Pathology and Laboratory Medicine, University of Pennsylvania, Philadelphia, PA
3Center for Cellular Immunotherapies, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA
4Parker Institute for Cancer Immunotherapy, University of Pennsylvania, Philadelphia, PA
5Hematology Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD
6Department of Pathology & Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA
7Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA
8Parker Institute for Cancer Immunotherapy, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA

Aileen G Rowan1*, Kanagaraju Ponnusamy, PhD2*, Hongwei Ren, PhD2*, Graham Phillip Taylor, MB ChB, DSc, FRCP, FHEA1,3*, Lucy Cook, MD PhD1,3,4* and Anastasios Karadimitris, MD, PhD2,4*

1Department of Infectious Disease, Imperial College London, London, United Kingdom
2Hugh & Josseline Langmuir Centre for Myeloma Research, Centre for Haematology, Department of Inflammation and Immunity, Imperial College London, London, United Kingdom
3National Centre for Human Retrovirology, Imperial College Healthcare NHS Trust, London, United Kingdom
4Department of Haematology, Hammersmith Hospital, Imperial College Healthcare NHS Trust, London, United Kingdom

Sara Sleiman, MD1*, Nathan D Mathewson, PhD2*, Feng Shen, MD, PhD1*, Kelly Moynihan, PhD2*, Wei Chen, PhD2*, Paul Bessette, PhD2*, Chris Kimberlin, PhD2*, Danielle Pappas2*, Terrence Park2*, Andy Yeung, PhD2*, Ivana Djuretic, PhD2* and Saar Gill, MD, PhD1,3,4

1Center for Cellular Immunotherapies, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA
2Asher Biotherapeutics, South San Francisco, CA
3Division of Hematology-Oncology, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA
4Cellular Therapy and Transplantation, Abramson Cancer Center of the University of Pennsylvania, Philadelphia, PA

Hope Fury1,2*, Xiaoqun Guan, PhD1,2*, Tyler Atagozli1,2*, David E. Elliot, MD PhD1,2*, Bruce R. Blazar, MD3 and M. Nedim Ince, MD1,2*

1University of Iowa Hospitals and Clinics, Iowa City, IA
2Iowa City VA Health Care System, Iowa City, IA
3University of Minnesota, Minneapolis, MN

Kun Yun1,2,3, Reona Leo Sakemura, MD, PhD1,4, Michelle J. Cox, Ph.D.1,4, Truc Huynh1,4*, Claudia Manriquez-Roman1,2,5,6, Olivia Sirpilla, BS1,3,7, Carli M. Stewart, BS1,7,8, James H. Girsch1,2,3*, Ekene J. Ogbodo, Ph.D.1,4*, Ismail Can9,10,11*, Brooke Kimball1,4*, Lionel A. Kankeu Fonkoua, M.D.1,12, Mehrdad Hefazi, M.D.1,4, Michael W. Ruff, M.D.1,13*, Elizabeth L. Siegler, Ph.D.1,4*, Mike Mattie, PhD14*, Sao-Mai Nguyen-Mau15*, Simone Filosto, PhD14* and Saad S. Kenderian, MD16

1T Cell Engineering, Mayo Clinic, Rochester, MN
2Department of Molecular Medicine, Mayo Clinic, Rochester, MN
3Mayo Clinic Graduate School of Biomedical Sciences, Rochester, MN
4Division of Hematology, Mayo Clinic, Rochester, MN
5Graduate School of Biomedical Sciences, Mayo Clinic Graduate School of Biomedical Sciences, Rochester, MN
6Regenerative Sciences PhD Program, Mayo Clinic, Rochester, MN
7Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic, Rochester, MN
8Graduate School of Biomedical Sciences, Mayo Clinic, Rochester, MN
9Mayo Clinic, Rochester, MN
10Department of Molecular Medicine, Mayo Clinic, Rochester
11Department of Biochemistry and Molecular Biology, Mayo Clinic, Rochester, MN
12Department of Oncology, Mayo Clinic, Rochester, MN
13Department of Neurology, Mayo Clinic, Rochester, MN
14Kite, a Gilead Company, Santa Monica, CA
15Kite Pharma, Inc, a Gilead company, Santa Monica, CA
16T Cell Engineering, Division of Hematology, Department of Molecular Medicine and Department of Immunology, Mayo Clinic, Rochester, MN

Jin Jin1*, Jiali Cheng1*, Na Wang, MD, PhD1*, Liang Huang, MD2, Xiaoxi Zhou, MD, PhD1*, Liting Chen, PhD1*, Hui Luo2*, Tianjiao Liu3* and Jiao Meng3*

1Department of Hematology, Tongji Hospital of Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
2Department of Hematology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
3Department of Hematology, Cancer Hospital of Harbin Medical University, Harbin, China

Won Lee, PhD1*, Destanie Rose, PhD1*, Mingshan Cheng, PhD1*, Heather Gustafson, PhD2*, Rebecca A Gardner, MD3,4,5, James G Keck, PhD1* and Jiwon Yang, PhD1*

1Innovation & Product Development, The Jackson Laboratory, Sacramento, CA
2Ben Towne Center for Childhood Cancer Research, Seattle, WA
3Division of Hematology-Oncology, Seattle Children's Hospital, Seattle, WA
4Seattle Children’s Hospital, Seattle, WA
5Seattle Children's Therapeutics, Seattle Children's Research Institute, Seattle, WA

Jin Zhang, PhD1,2,3, Anhua Lei4*, Lin Tian4*, Li Zhang4*, Shan Lu4*, Hengxing Lu4,5* and Mengmeng Zhu6*

1Zhejiang University School of Medicine, Hangzhou, Zhejiang, China
2Liangzhu Laboratory, Hangzhou, Zhejiang, China
3Department of Hematology, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, China
4Zhejiang University School of Medicine, Hangzhou, China
5Liangzhu Laboratory, Hangzhou, China
6CellOrigin Inc., Hangzhou, China

Jay A. Read, MD, PhD1,2, Feiyan Mo2,3*, Maksim Mamonkin, PhD2,4, Rayne H. Rouce, MD1,2 and Katherine Y. King, MD, PhD2,5

1Department of Pediatrics, Division of Hematology and Oncology, Baylor College of Medicine, Texas Children's Hospital, Houston, TX
2Center for Cell and Gene Therapy, Baylor College of Medicine, Texas Children's Hospital and Houston Methodist Hospital, Houston, TX
3Baylor College of Medicine, Texas Children's Hospital, Houston, TX
4Department of Pathology & Immunology, Baylor College of Medicine, Texas Children's Hospital, Houston, TX
5Division of Infectious Diseases, Department of Pediatrics, Baylor College of Medicine, Houston, TX

Klaudyna Fidyt, MSc1*, Marta Krawczyk, MSc1,2*, Monika Pepek, MSc1*, Katsiaryna Marhelava, PhD1*, Agnieszka Kraft3,4*, Malgorzata Bobrowicz, PhD1*, Aleksandra Kusowska, MSc1*, Joanna Barankiewicz, MD5*, Przemyslaw Juszczynski, MD, PhD6*, Michal Smida, PhD, MSc7*, Myron Czuczman, MD8, Francisco Hernandez-Ilizaliturri, MD9, Malgorzata Firczuk1,2* and Magdalena Winiarska1,2*

1Department of Immunology, Medical University of Warsaw, Warsaw, Poland
2Laboratory of Immunology, Mossakowski Medical Research Institute, Polish Academy of Sciences, Warsaw, Poland
3Faculty of Mathematics and Information Science, Warsaw University of Technology, Warsaw, Poland
4Laboratory of Functional and Structural Genomics, Centre of New Technologies, University of Warsaw, Warsaw, Poland
5Department of Hematology, Institute of Hematology and Transfusion Medicine, Warsaw, Poland
6Department of Experimental Hematology, Institute of Hematology and Transfusion Medicine, Warsaw, Poland
7Central European Institute of Technology (CEITEC), Masaryk University, Brno, Czech Republic
8Department of Hematologic Oncology, Roswell Park Comprehensive Cancer Center, Buffalo, NY
9Department of Medical Oncology, Roswell Park Comprehensive Cancer Center, Buffalo, NY

Justin C. Boucher, PhD1, Bishwas Shrestha, PhD1, Paresh Vishwasrao, MS1*, Mark B. Leick, MD2*, Nhan Tu, PhD1*, Tayyebb Ghafoor1*, Kayla M. Reid, M.S.1*, Kristen Spitler1*, Bin Yu1*, Marcela V. Maus, MD3 and Marco L. Davila, MD, PhD1

1Division of Clinical Science, Moffitt Cancer Center, Tampa, FL
2Cellular Immunotherapy Program, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA
3Cellular Immunotherapy Program, Massachusetts General Hospital Cancer Center, Harvard Medical School, Lexington, MA

Peter Sullivan, PhD1*, Yue Zhang, MS1*, Virginia Hoglund1*, Sophie Jamet, PhD1*, Isela J Garcia, BS1* and Rimas J Orentas, PhD1,2,3

1Ben Towne Center for Childhood Cancer Research, Seattle Children's Research Institute, Seattle, WA
2Caring Cross, Inc., Gaithersburg, MD
3Pediatrics, University of Washington School of Medicine, Seattle, WA

Hannah Reimann, PhD1*, Anita Natalie Kremer, MD, PhD2*, Viktoria Blumenberg, MD3,4,5, Katja Schmidt6*, Michael Aigner, PhD7*, Andreas Kremer, MD, PhD8,9*, Matthias Tenbusch10*, Heiko Bruns, PhD2*, Thomas Harrer6*, Georg Schett, MD11*, Fabian Mueller, MD7*, Andreas Mackensen, MD12*, Marion Subklewe, MD13,14,15 and Simon Voelkl, PhD7*

1Department of Internal Medicine 5 - Hematology/Oncology, University Hospital Erlangen, Erlangen, DEU
2Department of Internal Medicine 5 - Hematology/Oncology, University Hospital Erlangen, Erlangen, Germany
3Laboratory for Translational Cancer Immunology, LMU Gene Center, Munich, Germany
4Department of Medicine III, University Hospital, LMU Munich, Munich, Germany
5German Cancer Consortium (DKTK) and German Cancer Research Center (DKFZ), Partner Site Munich, Heidelberg, Germany
6Department of Internal Medicine 3 - Rheumatology and Immunology, University Hospital Erlangen, Erlangen, Germany
7Department of Internal Medicine 5 - Hematology/Oncology, University Hospital of Erlangen, Erlangen, Germany
8Department of Gasteroenterology and Hepatology, University Hospital Zürich, Zürich, Switzerland
9Department of Internal Medicine 1, University Hospital Erlangen, Erlangen, DEU
10Institute of Clinical and Molecular Virology, University Hospital Erlangen, Erlangen, Germany
11Department of Internal Medicine 3, University Hospital of Erlangen, Erlangen, Germany
12Department of Internal Medicine 5, Hematology and Oncology, University Hospital Erlangen, Erlangen, Germany
13German Cancer Consortium (DKTK) and German Cancer Research Center (DKFZ), Heidelberg, Germany
14Department of Medicine III (Hematology/Oncology), LMU University Hospital Munich, Muenchen, Germany
15Laboratory for Translational Cancer Immunology, Gene Center, LMU Munich, Munich, Germany

Luis Gerardo Rodríguez-Lobato, MD, PhD1*, Oriol Cardus, MSc1*, Joan Mañe-Pujol, MSc1*, Anthony M Battram, PhD1*, Lorena Pérez-Amill, PhD1*, Hugo Calderón, PhD1*, Beatriz Martin-Antonio, PhD2*, Aina Oliver-Caldes, MD1*, Agnès Garcias-López, PhD1*, Ester Lozano, PhD1*, David F. Moreno, MD1*, Valentín Ortiz-Maldonado, MD3*, Maria Queralt Salas, MD1*, Anna de Daniel i Bisbe, MD1*, Natalia Tovar, MD, PhD1*, Raquel Jiménez-Segura, MD1*, M. Teresa Cibeira, MD, PhD1*, Laura Rosinol Dachs1*, Joan Bladé Creixenti, MD, PhD1, Manel Juan, MD, PhD4*, Álvaro Urbano-Ispizua, MD, PhD1, Pablo Engel, MD, PhD5* and Carlos Fernandez de Larrea, MD1

1Amyloidosis and Myeloma Unit, Hospital Clínic, Barcelona, Institut d’Investigacions Biomèdiques August Pi I Sunyer (IDIBAPS), University of Barcelona, Barcelona, Spain
2Instituto de Investigación Sanitaria-Fundación Jimenez Diaz, Madrid, Spain
3Hematology Department, Institut Clínic de Malalties Hemato-Oncològiques (ICMHO), IDIBAPS, Hospital Clínic, Barcelona. Institut d’Investigacions Biomèdiques August Pi I Sunyer (IDIBAPS), University of Barcelona, Barcelona, Spain
4Department of Immunology, Hospital Clínic de Barcelona. IDIBAPS. University of Barcelona, Barcelona, Spain
5Department of Biomedical Sciences, University of Barcelona, Barcelona, Spain

Smitha Hosahalli Vasanna, MD, MBBS1, Reshani Perera, Ph.D2*, Zachary Jackson, PhD Candidate3*, Eric Abenojar, PhD Candidate4*, Agata Exner, Ph.D5* and David Wald, MD, Ph.D6*

1Rainbow Babies and Childrens Hospital, Cleveland, OH
2Radiology Department, Case Western Reserve University, Cleveland, OH
3Pathology, Case Western Reserve University, Cleveland, OH
4Department of Radiology, Case Western Reserve University, Cleveland, OH
5Department of Radiology, Case Western Reserve University/ University Hospitals of Cleveland, Cleveland, OH
6Department of Pathology, Case Western Reserve University/ University Hospitals of Cleveland, Cleveland, OH

Caroline Diorio, MD1, Tiffaney L. Vincent2*, Tori Fuller3*, Rawan Shraim, MSc4*, Tina Glisovic-Aplenc, PhD5, Theresa Ryan6*, Kimberly Veliz7*, Haley Newman, MD2, Gerald Wertheim, MD, PhD8, Hamid Bassiri, MD PhD9*, Annette Vu1*, Michael Hogarty, MD10*, Carl H June, MD11, Stephan A. Grupp, MD, PhD2, Sarah K Tasian, MD12, Richard Aplenc, MD, PhD13, Saar Gill, MD, PhD14,15 and David T. Teachey, MD16

1Center for Childhood Cancer Research, Children's Hospital of Philadelphia, Philadelphia, PA
2Division of Oncology, Children's Hospital of Philadelphia, Philadelphia, PA
3Children's Hospital of Philadelphia, Norristown, PA
4Department of Pediatrics and the Center for Childhood Cancer Research, Children's Hospital of Philadelphia, Philadelphia, PA
5The Children's Hospital of Philadelphia, Philadelphia, PA
6Children's Hospital of Philadelphia, Philadelphia, PA
7University of Pennsylvania, Philadelphia, PA
8Division of Hematology/Oncology, Department of Medicine, The Perelman School of Medicine at The University of Pennsylvania, Philadelphia, PA
9Immune Dysregulation Frontier Program, Department of Pediatrics, Children's Hospital of Philadelphia, Philadelphia, PA
10Children's Hospital of Phil, Philadelphia, PA
11Center for Cellular Immunotherapies (CCI), The University of Pennsylvania, Perelman School of Medicine, Philadelphia, PA
12Division of Oncology and Center for Childhood Cancer Research, Children’s Hospital of Philadelphia, Philadelphia, PA
13Division of Oncology and Center for Childhood Cancer Research, The Children's Hospital of Philadelphia, Philadelphia, PA
14Center for Cellular Immunotherapies, University of Pennsylvania School of Medicine, Philadelphia, PA
15Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA
16Department of Pediatrics and the Center for Childhood Cancer Research, Children's Hospital of Philadelphia, Rutledge, PA

Yi Wang, MD1*, Hui Wang1*, Ben Niu1*, Ying Gao, MD1*, Ding Zhang1*, Yudi Miao2*, Wei Zhou, Bachelor3*, Limin Hou1*, Hong Zhang, Bachelor3*, Xingxing Hu1*, Fangyuan Wang4*, Lan Li2*, Xingli Ru1*, Weihua Zhang1*, Xiang Li5* and Feng Guan6*

1Department of Hematology, Shaanxi Provincial People's Hospital, Xi'an, China
2Shaanxi Provincial People’s Hospital, Xi'an, China
3Deparment of Hematology, Shaanxi Provincial People's Hospital, XI’an, China
4School of Medicine, Stanford University, Palo Alto
5Northwest University, Xi'an, China
6Northwest University, College of Life Science, Xi'An, China, Xi`An, Shaanxi, CHN

Zachary Davis, PhD1*, Frank Cichocki, PhD1*, Martin Felices, PhD1*, Hongbo Wang1*, Peter Hinderlie1*, Mark Juckett, MD1, Joseph Maakaron, MD1*, Gregory I. Berk, MD2, Bryan Hancock, PhD3*, John Goulding, PhD3*, Ryan Bjordahl4*, Bahram Valamehr3 and Jeffrey S. Miller, MD, MD1

1Masonic Cancer Center, University of Minnesota, Minneapolis, MN
2GT BioPharma, Inc., Brisbane, CA
3Fate Therapeutics, Inc., San Diego, CA
4Fate Therapeutics, San Diego, CA

Sjoukje Van Der Stegen, PhD1*, Roseanna M. Petrovic, PhD1*, Pieter L. Lindenbergh1*, Mame P. Diop1*, Vera Alexeeva1*, Hongyao Xie1*, Raedun Clarke, PhD2*, Bahram Valamehr3, Isabelle Riviere, PhD4 and Michel Sadelain, MD, PhD1

1Center for Cell Engineering, Memorial Sloan Kettering Cancer Center, New York, NY
2Fate Therapeutics Inc., San Diego, CA
3Fate Therapeutics, Inc., San Diego, CA
4Cell Therapy and Cell Engineering Facility, Memorial Sloan Kettering Cancer Center, New York, NY

Miranda H. Meeuwsen1*, Anne K. Wouters1*, Tassilo L.A. Wachsmann1*, Renate S. Hagedoorn1*, Dennis F.G. Remst1*, Michel G.D. Kester1*, Dirk M. van der Steen1*, Arnoud H. de Ru2*, Peter A. van Veelen2*, J.H. Frederik Falkenburg1* and Mirjam H.M. Heemskerk1

1Department of Hematology, Leiden University Medical Center, Leiden, Netherlands
2Center for Proteomics and Metabolomics, Leiden University Medical Center, Leiden, Netherlands

Wenjing Luo1,2*, Chenggong Li1,2*, Jianghua Wu1,2*, Yinqiang Zhang1,2*, Lu Tang1,2*, Mengyi Du1,2*, Xindi Wang1,2*, Wei Xiong3*, Haiming Kou1,2*, Cong Lu1,2*, Heng Mei1,2* and Yu Hu1,2*

1Institute of Hematology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
2Hubei Clinical Medical Center of Cell Therapy for Neoplastic Disease, Wuhan, China
3Wuhan Sian Medical Technology Co., Ltd, Wuhan, China

*signifies non-member of ASH